• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD Back to Search Results
Catalog Number UNK ABSORB
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Low Blood Pressure/ Hypotension (1914); Myocardial Infarction (1969); Perforation (2001); Pericardial Effusion (3271)
Event Date 03/06/2017
Event Type  Injury  
Event Description
It was reported through a research article, identifying the 3.5×28mm absorb bio-resorbable vascular scaffold (bvs) system as follows: a patient presented for a percutaneous coronary intervention (pci) to treat a mildly calcified lesion in the proximal left anterior descending artery (plad) with a 3.5x28mm absorb bio-absorbable vascular scaffold (bvs).Following pre-dilation and deployment of the 3.5×28mm absorb bvs, high pressure post-dilation was performed, after which a perforation, hypotension, chest pain and st elevation were noted.Hemostasis of the perforation was attempted with prolonged balloon dilation, which was unsuccessful, so they implanted a non-abbott covered stent, which resolved the issue restoring blood flow and covering the perforation.The patient was discharged 3 days later.Repeat angiography at 3 months showed patent stents with timi iii flow, and optical coherence tomography (oct) showed good expansion and apposition of the proximal absorb bvs.The patient has remained well 4 years after pci with no major cardiovascular events.Details are listed in the attached article, titled coronary artery perforation after bio-resorbable scaffold implantation treated with a new generation covered stent¿ oct insights please see article for additional information.
 
Manufacturer Narrative
Date of event: estimated.The unique device identifier (udi) is unknown because the part number and lot number were not provided.Date of implant: estimated.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record and complaint history could not be conducted because the part and lot number were not provided.The reported patient effects of angina, hypotension, perforation, pericardial effusion and myocardial infarction, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined and the treatment appears to be related to the circumstances of the procedure.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.Article, titled coronary artery perforation after bio-resorbable scaffold implantation treated with a new generation covered stent¿ oct insights.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE SCAFFOLD
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13875718
MDR Text Key288367949
Report Number2024168-2022-03070
Device Sequence Number1
Product Code PNY
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK ABSORB
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
3.0 MM HIRYU NON-COMPLIANT MONORAIL BALLOON; 3.5 MM HIRYU NON-COMPLIANT MONORAIL BALLOON; EBU 4.0 GUIDE CATHETER; ILUMIEN OPTIS PCI OPTIMISATION INTRAVASCULAR IMAGI; SHORT 4.0 MM HIRYU NON-COMPLIANT MONORAIL BALLOON
Patient Outcome(s) Required Intervention; Disability;
Patient Age46 YR
Patient SexMale
-
-